About Crest Biologics
Crest Biologics is a Healthcare company. Dental products distribution and partnerships in the healthcare sector. The company has 1 employees. Its Indian entity Crest Biologics Private Limited reported revenue of ₹7.88 Cr. Crest Biologics offers products and services including Bone Grafts and Surgical Instruments. Its focus areas include Surgical Supplies, Dental Equipment, Loupes and Lights and Medical Devices.
Company details
Crest Biologics Pvt. Ltd. was established in 2022 following the acquisition of the NovaBone company by Halma UK, PLC in 2020, where products, personnel, and agreements were transferred to form the new entity. It is noted as the exclusive distributor of NovaBone devices for the Indian Subcontinent, with commitments made to expand the product portfolio through partnerships with global leaders like Collagen Matrix, Dowell, Osteogenics, and BiLumix. Operations are based in Bangalore, India, focusing on dental products such as bone grafts, surgical instruments, and loupeslights, ensuring continued distribution in the healthcare field.
- Employees 1
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website crestbiologics.com
- Legal Name Crest Biologics Pvt. Ltd
- Date of Incorporation 03 Aug, 2021
- Jurisdiction Bangalore, Karnataka, India
- Indian entity revenue₹7.88 Cr
FY 2025 · +18% YoY
- Indian entity net profit₹50.4 Lakh
FY 2025 · 6% margin
- Indian entity EBITDA₹69.5 Lakh
FY 2025 · 9% margin
- Employee Count1
Associated legal entities of Crest Biologics
Crest Biologics operates through Crest Biologics Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Crest Biologics Private Limited CIN U29200KA2021PTC150242 | Active | 03 Aug 2021 | Bangalore, Karnataka | ₹7.9 Cr | 3 | View details |
Products & Services of Crest Biologics
Crest Biologics offers a comprehensive portfolio of products and services, including Bone Grafts and Surgical Instruments.
Bone grafts are supplied for dental procedures as part of the company's distribution efforts
Surgical instruments are provided for dental applications through established partnerships
Board of directors of Crest Biologics Private Limited (Crest Biologics)
Crest Biologics Private Limited is the primary company behind Crest Biologics. The board of Crest Biologics Private Limited currently have 3 directors; the longest-serving is Susheela Aswath Katta, appointed in 2021.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Susheela Aswath Katta DIN 09093769 | Director | 03 Aug 2021 | 5 yrs 3 mo | Crest Biologics Private Limited |
| Katta Narayanaiah Aswathanarayanagupta DIN 07965460 | Director | 03 Aug 2021 | 5 yrs 3 mo | Crest Biologics Private Limited |
| Sunitha Bagepalli Ashwathanarayana DIN 11537635 | Additional Director | 11 Feb 2026 | 8 mo | Crest Biologics Private Limited |
Financials of Crest Biologics
Figures of Crest Biologics Private Limited, the primary company behind Crest Biologics, for FY 2025. Revenue was ₹7.88 Cr (+18% year on year). Net profit was ₹50.4 Lakh (6% margin). EBITDA was ₹69.5 Lakh (9% margin).
- ₹7.88 CrRevenue · FY 2025 · +18% YoY
- ₹50.4 LakhNet profit · 6% margin
- ₹69.5 LakhEBITDA · 9% margin
- ₹1 LakhPaid-up capital
Balance sheet, profit and loss, cash flow and ratios of Crest Biologics Private Limited are on its company page.
Detailed financial statements for Crest Biologics
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Crest Biologics
Crest Biologics has 1 employees.
The primary company behind Crest Biologics, Crest Biologics Private Limited, reported revenue of ₹7.88 Cr for FY 2025, up 18% year on year.
Crest Biologics Pvt. Ltd. was established in 2022 following the acquisition of the NovaBone company by Halma UK, PLC in 2020, where products, personnel, and agreements were transferred to form the new entity. It is noted as the exclusive distributor of NovaBone devices for the Indian Subcontinent, with commitments made to expand the product portfolio through partnerships with global leaders like Collagen Matrix, Dowell, Osteogenics, and BiLumix. Operations are based in Bangalore, India, focusing on dental products such as bone grafts, surgical instruments, and loupeslights, ensuring continued distribution in the healthcare field.
Crest Biologics offers Bone Grafts and Surgical Instruments.
Crest Biologics operates through Crest Biologics Private Limited.
The legal entities of Crest Biologics currently have 3 directors, including Susheela Aswath Katta, Katta Narayanaiah Aswathanarayanagupta, Sunitha Bagepalli Ashwathanarayana.